Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Developing a New Imaging Method for Sensitive Detection of Early Glaucoma Damage Updated On: Jan. 21, 2025
National Glaucoma Research Grant

Developing a New Imaging Method for Sensitive Detection of Early Glaucoma Damage

Imaging & Exploring the Eye-Brain Connection
Xiangrun Huang, PhD

Principal Investigator

Xiangrun Huang, PhD

University of Miami Miller School of Medicine

Miami, FL, USA

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$150,000

Active Dates

July 01, 2018 - June 30, 2020

Grant ID

G2018148

Acknowledgement

Recipient of The Dr. Douglas H. Johnson Award

Goals

Glaucoma, a leading cause of blindness worldwide, damages a type of neuronal cells called retinal ganglion cells and their nerve fibers, known as axons, in the eye. Early detection of abnormities of the nerve fibers can permit early medical intervention to prevent vision loss in glaucomatous patients. The proposed research will develop a new optical imaging method that detects abnormities of the light reflected by the nerve fibers. The new approach can provide sensitive detection of the abnormities that occur at early stages of glaucoma. If successful, the developed methods can be readily translated to clinical use and provide clinicians with a new means to sensitively detect early glaucomatous damage, opening an early therapeutic window for the prevention of glaucomatous damage and vision loss.

Summary

Currently the clinical diagnosis of glaucoma most often uses measurements of the thickness of the retinal nerve fiber layer; and these measurements are unable to detect glaucomatous damage at early stages of the disease. Studies have shown that glaucoma causes change in the light reflected by the nerve fibers; in addition, this occurs prior to thickness change. The proposed research will develop a new optical imaging method that detects abnormalities of the light reflected by the nerve fibers of glaucomatous retinas. If successful, the developed methods can be readily translated to clinical use and provide clinicians with a new means to detect glaucoma at an early stage, opening a therapeutic window for the prevention of progressive and irreversible vision loss.